ANGIOTENSIN I-CONVERTING ENZYME (ACE) INHIBITORS

• 1. 含有α-硫辛酸、氨溴索和/或血管紧张素转化酶(ACE)抑制剂的药物制剂及其治疗神经变性疾病的用途 [P] . 中国专利： CN1530102B . 2010.12.08
• 2. 含有α－硫辛酸、氨溴索和/或血管紧张素转化酶(ACE)抑制剂的药物制剂及其治疗神经变性疾病的用途 [P] . 中国专利： CN1530102A . 2004-09-22
• 3. ANGIOTENSIN I-CONVERTING ENZYME (ACE) INHIBITORS [P] . 欧洲知识产权局专利： EP1899365B1 . 2012-09-12

  机译： 血管紧张素I转化酶（ACE）抑制剂

• 4. Angiotensin I-converting enzyme (ACE) inhibitors [P] . 美国专利： US7951834B2 . 2011-05-31

  机译： 血管紧张素I转换酶（ACE）抑制剂

• 5. Angiotensin I-converting enzyme (ACE) inhibitors [P] . 美国专利： US7981922B2 . 2011-07-19

  机译： 血管紧张素I转换酶（ACE）抑制剂

• 1. Microwave-assisted Solid-phase Synthesis, Biological Evaluation and Molecular Docking of Angiotensin I-converting Enzyme Inhibitors [J] . SUN Yang, HUANG Da-wei, LI Xiao-hui, 高等学校化学研究（英文版） . 2012,第001期
• 2. Microwave-assisted Solid-phase Synthesis, Biological Evaluation and Molecular Docking of Angiotensin I-converting Enzyme Inhibitors [J] . 无 高等学校化学研究：英文版 . 2012,第001期
• 3. Optimization of angiotensin I-converting enzyme (ACE) inhibition by rice dregs hydrolysates using response surface methodology [J] . HE Guo-qing, XUAN Guo-dong, RUAN Hui, 浙江大学学报（英文版）（B辑：生物医学和生物技术） . 2005,第006期
• 4. RXP 407, a Selective Inhibitor of the N-Domain of Angiotensin I-Converting Enzyme,Blocks in Vivo the Degradation of Hemoregulatory Peptide Acetyl-Ser-Asp-Lys-Pro with No Effect on Angiotensin I Hydrolysis [J] . The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics . 2001,第2期
• 5. Angiotensin I-converting enzyme (ACE) inhibitors and restenosis after coronary artery stenting in patients with the DD genotype of the ACE gene. [J] . Koch W, Mehilli J, von Beckerath N, Journal of the American College of Cardiology . 2003,第11期
• 6. Molecular insights into the interaction of angiotensin I-converting enzyme (ACE) inhibitors and HEXXH motif [J] . Kircheva Nikoleta, Dobrev Stefan, Yakimova Boryana, Biophysical Chemistry: An International Journal Devoted to the Physical Chemistry of Biological Phenomena . 2021,第1期
• 7. Development of Domain-Selective Angiotensin I-Converting Enzyme Inhibitors [C] . PIERRE REDELINGHUYS, ALOYSIUS T. NCHINDA, EDWARD D. STURROCK International Conference on Natural Products and Molecular Medicine . 2005
• 8. Utilization of Vasopressin as a First Line Response to Perioperative Hypotension in the Patient on Angiotensin Receptor Antagonists and Angiotensin Converting Enzyme Inhibitors [D] . Buckley, Emily A. 2015
• 9. Elevation of the antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline: a blood pressure-independent beneficial effect of angiotensin I-converting enzyme inhibitors [O] . Megumi Kanasaki, Takako Nagai, Munehiro Kitada, 2011
• 10. Angiotensin I-converting enzyme inhibitors derived from an enzymatic hydrolysate of casein. Part IV Studies on the active site and antihypertensive activity of angiotensin I-converting enzyme inhibitors derived from casein. [O] . Susumu MARUYAMA, Hajime MITACHI, Hideoki TANAKA, 1987
• 11. Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors (ACEls) and Angiotensin II Receptor Antagonists (ARBs) for Treating Essential Hypertension. Comparative Effectiveness Review, Number 10 [R] . Matchar, D. B., McCrory, D. C., Orlando, L. A., 2007

• 1. Role of angiotensin converting enzyme and angiotensinogen gene polymorphisms in angiotensin converting enzyme inhibitor-mediated antiproteinuric action in type 2 diabetic nephropathy patients [J] . Neerja Aggarwal ,Pawan Kumar Kare ,Parul Varshney . 世界糖尿病杂志：英文版（电子版） . 2017,第3期
• 2. iMorinda citrifolia/i(Noni) Fruit Juice Inhibits SARS-CoV-2 Spike Protein Binding of Angiotensin-Converting Enzyme 2 (ACE2) [J] . Brett J. West ,Shixin Deng . 生物科学与医学(英文) . 2021,第11期
• 3. 2001-2011年福建急性心肌梗死患者血管紧张素转化酶抑制剂和血管紧张素受体阻滞剂的应用及影响因素 [C] . 廖颖 ,陈开红 ,方勇 . 第19届中国南方国际心血管病学术会议 . 2017
• 4. 血管紧张素转化酶抑制剂和血管紧张素受体Ⅱ抑制剂对胃恶性肿瘤合并高血压患者化疗疗效及预后影响 [A] . 戚雅君 . 2017